⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
ABBV News
ABBVIE INC.
2026 Back of the Eye Disorders Market Research Report (2nd Edition): A Development Pipeline Consisting of ~690 Approved or Clinical-Stage Therapeutic Candidates
globenewswire.com
KODK
OTLK
ALDX
OCUL
REGN
ABBV
NVS
BHC
SUN
AbbVie Announces Positive Topline Results from the Phase 3 CERVINO Trial Showing Etentamig Significantly Improved Response Rate and Progression-Free Survival in Patients with Relapsed/Refractory Multiple Myeloma
prnewswire.com
ABBV
Form 8-K
sec.gov
ABBV
AbbVie Completes Acquisition of Apogee Therapeutics
prnewswire.com
ABBV
APGE
Direct Relief Medical Aid to U.S. Safety Net Tops $3 Billion
accessnewswire.com
TEVA
LLY
ABBV
ALC
JNJ
SNY
PFE
FDX
ABT
Autoimmune Uveitis Market to Expand at a CAGR of 7% During the Forecast Period (2026-2036) as Novel Treatments Challenge the Existing Therapeutic Landscape | DelveInsight
prnewswire.com
ABBV
AMGN
BMY
NVS
PFE
UNH
Allergan Aesthetics Unveils the Layered Beauty Report, Advancing the Global Conversation Around Aesthetic Care
prnewswire.com
ABBV
A Wave of Weight-Loss Drugs Is Quietly Creating a Multi-Billion-Dollar Opportunity That Aesthetic Medicine Is Racing to Capture
prnewswire.com
INMD
EOLS
ABBV
CNXU
ESTA
SkinMedica® Adds Barrier Calming Cream to its Collection of Regenerative Skincare Offerings
prnewswire.com
ABBV
Global Breast Implants Market to Reach USD 5.2 Billion by 2032 as Augmentation and Reconstruction Demand Expands
globenewswire.com
ABBV
JNJ
ESTA